MAPT and Alzheimer disease: Our previous work on Alzheimer Disease (AD) demonstrated that Syk regulates Tau phosphorylation by controlling the activation of glycogen synthase 3β (Paris et al., 2014), thus sections were immunostained for p-Syk.